造血调控因子HAPO、PF4对造血干细胞调节的体内外研究
本文关键词:造血调控因子HAPO、PF4对造血干细胞调节的体内外研究 出处:《中国协和医科大学》2005年博士论文 论文类型:学位论文
更多相关文章: 血液血管细胞生成素 CD133~+细胞 增殖 粘附性 趋化作用 造血重建 化疗 减毒沙门氏菌 PF4 5-氟尿嘧啶
【摘要】:目的 研究人促血液血管细胞生成素(Hemangiopoietin,HAPO)对CD133~+造血干细胞的作用,探讨其生物学功能。方法 采用细胞液体培养、半固体培养、免疫荧光标记流式细胞仪测定、显微镜观察照相等方法。结果 1.在加SCF、TPO、IL-3的无血清无基质培养体系中,培养的人骨髓CD133~+细胞,,7天时流式细胞仪测定对照组CD133~+细胞含量为41.92%,HAPO组CD133~+细胞含量为56.70%;HAPO组中CD133~+细胞数由原来的6.8×10~4增加为(2.88±0.12)×10~6,细胞数扩增了41.98倍;对照组中CD133~+细胞数由原来的6.8×10~4增加为(1.79±0.02)×10~6,细胞数扩增了26.09倍;10天时流式细胞仪测定对照组CD133~+细胞含量为32.60%,HAPO组CD133~+细胞含量为49.02%;HAPO组中CD133~+细胞数扩增了356倍,而对照组中CD133~+细胞数扩增了98倍。2.扩增7天时,流式细胞仪测定对照组细胞粘附分子CD31细胞含量对照组为68.27%,HAPO组CD31细胞含量为76.89%;细胞粘附分子CD49d表达对照组80.11%、HAPO组CD49d细胞含量为88.17%。3.将5×10~3个CD133~+细胞接种到1ml甲基纤维素半固体集落培养基中,PBS对照组生成GM-CFU 134.5±9.2个,HAPO组生成GM-CFU 167.5±4.5个,
[Abstract]:Objective to study the effect of human Hemangiopoietin (HAPO) on CD133~+ hematopoietic stem cells and to explore its biological function. Methods the methods of cell culture, semisolid culture, immunofluorescent labeling flow cytometer and microscope observation were used. Results 1. in SCF, TPO, IL-3 and serum-free medium culture system, human bone marrow CD133~+ cells cultured for 7 days, when the flow cytometry content of CD133~+ cells control group 41.92%, HAPO group of CD133~+ cells was 56.70%; the number of CD133~+ cells in the HAPO group from the original 4 increased to 6.8 * 10~ (2.88 + 0.12) * 10~6, the cell number was 41.98 times; the control group: the number of CD133~+ cells from 6.8 * 10~4 to increase (1.79 + 0.02) * 10~6, the cell number was 26.09 times; 10 days were determined by flow cytometry in CD133~+ cells of control group was 32.60%, HAPO group of CD133~+ cells the content is 49.02%; the number of CD133~+ cells in HAPO group was 356 times, while the control group in the number of CD133~+ cells was 98 times. 2. after 7 days of amplification, flow cytometry was used to determine the cell adhesion molecule CD31 cell content in the control group, 68.27% in the control group, and 76.89% in the HAPO group, while the CD49d expression in the cell adhesion molecule was 80.11% in the control group and 88.17% in the HAPO group, and the CD49d cell content in the CD31 group was 88.17%. 3., 5 x 10~3 CD133~+ cells were inoculated into 1ml semi-solid medium, and PBS control group generated GM-CFU 134.5 + 9.2, HAPO group generated GM-CFU 167.5 + 4.5.
【学位授予单位】:中国协和医科大学
【学位级别】:博士
【学位授予年份】:2005
【分类号】:R329
【参考文献】
相关期刊论文 前10条
1 张学忠,陈玉心,汪承亚,敖忠芳;脐血血浆与rhGM-CSF对正常骨髓细胞生长影响的比较研究[J];中国输血杂志;1998年01期
2 汪江,颜维仁,吴梦杭;脐带血输注治疗再生障碍性贫血18例疗效观察[J];第三军医大学学报;2002年06期
3 伍钢;脐血造血干/祖细胞的特点和临床应用[J];国外医学(儿科学分册);1996年02期
4 陈公英;肝炎后肝硬化血液学异常的若干研究[J];国外医学(流行病学传染病学分册);2001年04期
5 刘志辉,韦劲松,胡晓桦,于起涛,康平,宋向群,廖萍;脐血输注对恶性肿瘤患者化疗后骨髓功能的保护作用的临床观察[J];广西医科大学学报;1999年06期
6 韦劲松,刘志辉,胡晓桦,周文献,伍楚容,于起涛,康平,李志革;脐血输注对恶性肿瘤患者化疗的辅助治疗作用[J];广西医科大学学报;1999年05期
7 张绍金;冯珏荪;巫加宁;蒋正明;张晓燕;;对98份脐血清IgG、IgM、AFP和HBsAg的检测和分析[J];湖北医学院学报;1983年04期
8 郑宣鹤,唐晓鹏,陈军,龚国忠,赖力英;血浆置换联合胎肝细胞悬液治疗重型肝炎[J];湖南医科大学学报;2001年05期
9 唐晓鹏,郑宣鹤,杨旭;脐血输注合并血浆置换治疗慢性重型肝炎的疗效初探[J];湖南医科大学学报;2002年04期
10 许文荣,胡嘉波,顾可梁;脐血造血干/祖细胞研究现状及临床应用[J];临床检验杂志;1999年05期
本文编号:1346098
本文链接:https://www.wllwen.com/yixuelunwen/binglixuelunwen/1346098.html